OVERVIEW

The diabetes care devices market size is expected to surpass USD 4.36 billion by 2026 on account of COVID-19, growing at a CAGR of 3.50 percent over the forecast period. With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies so as to stop the spread of this pandemic and supply optimum care to the infected also widens. additionally , till a pharmacological treatment is developed, ventilators act as an important treatment preference for the COVID-19 patients, who may require critical care. Moreover, there's an urgent need for a rapid acceleration within the manufacturing process for a good range of test-kits.

TABLE OF CONTENT

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 BRIC Diabetes Care Devices Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 BRIC Diabetes Care Devices Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 BRIC Diabetes Care Devices Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 BRIC Diabetes Care Devices Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 BRIC Diabetes Care Devices Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 BRIC Diabetes Care Devices Market ? By Type (Market Size ? & million/billion)
  • 8.1 Blood Glucose Monitoring Devices
  • 8.2 Insulin Delivery Devices

• 9 BRIC Diabetes Care Devices Market ? By Geography (Market Size ? & million/billion)
  • 9.1 Introduction
  • 9.2 Brazil
  • 9.3 Russia
  • 9.4 China
  • 9.5 India

• 10 BRIC Diabetes Care Devices Market ? Entropy
  • 10.1 New product launches
  • 10.2 M&A's, collaborations, JVs and partnerships

• 11 BRIC Diabetes Care Devices Market Company Profile (Key Players)
  • 11.1 Market Share, Company Revenue, Products, M&A, Developments
  • 11.2 Becton, Dickinson and Company
  • 11.3 Ypsomed AG
  • 11.4 Roche Diagnostics Limited
  • 11.5 Acon Laboratories, Inc.
  • 11.6 Medtronic PLC
  • 11.7 Johnson & Johnson
  • 11.8 Abbott Laboratories
  • 11.9 Bayer AG
  • 11.10 Sanofi
  • 11.11 Novo Nordisk A/S
  • 11.12 Company 11 & more

• 12 BRIC Diabetes Care Devices Market - Appendix
  • 12.1 Sources
  • 12.2 Abbreviations